Anticarcinogenic drug composition

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3120

Patent

active

058520570

ABSTRACT:
The invention provides an anticarcinogenic drug composition which effectively inhibits the recurrence of hepatocellular carcinoma (the occurrence of second primary tumor), the occurrence of hepatocellular carcinoma in high risk groups with chronic hepatitis and liver cirrhosis, the occurrence of cervical carcinoma intraepitheliale, lung adenocarcinoma, lung squamous cell carcinoma, mammary tumor, and the like and is highly safe. The anticarcinogenic drug composition contains 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid or a salt thereof.

REFERENCES:
patent: 4988732 (1991-01-01), Yamatsu et al.
Database WPIL, Derwent Publications, AN 86-267856, JP 61-194018, Aug. 28, 1986.
Database WPIL, Derwent Publications, AN 86-082985, EP 0175171, Mar. 26, 1986.
Database WPIL, Derwent Publications, AN 84-115750, EP 0107188, May 2, 1984.
Database WPIL, Derwent Publications, AN-81-60469D, BE 888290, Jul. 31, 1981.
Database WPIL, Derwent Publications, AN 83-784326, EP 0090378, Oct. 5, 1983 .

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Anticarcinogenic drug composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anticarcinogenic drug composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anticarcinogenic drug composition will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2048125

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.